Yachmetz Philip K

Savient Pharmaceuticals Inc.

Co-President and CBO

Avg. Two Year Performance

133% Avg. Purchase Return 53% Compound

37% Avg. Sale Return 17% Compound

Holdings: 90.55K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions